Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose IL-2 in Active Idiopathic Inflammatory Myopathy
NCT04237987Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of aldesleukin in dermatomyositis (DM), polymyositis (PM), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
aldesleukin
03
Conditions
dermatomyositis (DM)polymyositis (PM)
Beyond the preview
Go deeper on NCT04237987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04237987.